The legionnaires' disease bacterium, LegioneUa pneumophila, is a facultative intracellular parasite. Its interaction with phagocytes has characteristics in common with several other intracellular parasites. Critical aspects of L. pneumophila intracellular multiplication are evasion of lysosomal host cell defenses and the presence of a nutritionally appropriate environment. Following phagocytosis, wild-type
Intracellular parasites must employ mechanisms which allow them to evade host defenses and multiply inside a living cell. One of these is to multiply within a specialized phagosome which does not fuse with secondary lysosomes. As a model for understanding intracellular survival and multiplication among organisms which modify the endosomal pathway and occupy a specialized phagosome, we have focused on Legionella pneumophila, the agent of legionnaires' disease (1) . This Gram-negative bacterium attaches to the complement receptors of phagocytic cells (2) and enters these cells by coiling phagocytosis (3) . The L. pneumophila-containing phagosomes interact with host cell smooth vesicles, mitochondria, and ribosomes (4), but they do not become highly acidified and do not fuse with lysosomes (1, 5) . The bacteria are able to multiply exponentially within this specialized phagosome until the host cell eventually lyses, releasing bacteria to the extracellular environment to continue the infection cycle (6) .
We are interested in genetically dissecting this pathway to understand how L. pneumophila evades host defenses. A mutant which has lost the capacity to grow within and kill human macrophages was found to be unable to cause pneumonia in animals. Detailed studies of this mutant, 25D, revealed that after entering the host cell by coiling phagocytosis, phagosomes containing 25D fuse with lysosomes. Although 25D survives for up to 72 hr inside the phagolysosome it does not multiply (7) . We refer to this phenotype as 1cm-, for intracellular multiplication.
We have attempted to identify the locus or gene(s) from wild-type L. pneumophila which restores intracellular multiplication (Icm+) to the 25D mutant. To do this we required an assay that would allow us to identify infrequent clones with the Icm+ phenotype among a large population of Icmbacteria. We therefore developed a plaque assay for Icm+ L. pneumophila that uses human macrophages derived from phorbol-ester-differentiated HL-60 cells. This plaque assay allowed us to identify cosmids from a genomic library of wild-type L. pneumophila that complement the Icm-phenotype of 25D. The icm locus also restores the capacity of 25D to modify the endosomal pathway and to cause lethal pneumonia in the guinea pig model of legionnaires' disease.
MATERIALS AND METHODS
Bacterial Strains, Plasmids, and Media. Bacterial strains and plasmids used in these studies are described in Table 1 . L. pneumophila was grown either in AYE broth (11) or on ABCYE plates (12) . Escherichia coli was cultivated in LB broth or on LB agar (13) . Antibiotics for L. pneumophila were used at the following concentrations: kanamycin and streptomycin, 50 ,g/ml; chloramphenicol and gentamicin, 5 ,ug/ml. For E. coli, antibiotic concentrations were as follows: kanamycin, streptomycin, and carbenicillin, 50 ,ug/ml; chloramphenicol, 25 ,g/ml; gentamicin, 10 ,ug/ml; and tetracycline, 20 ,g/ml, unless otherwise noted.
Cell Culture. Human macrophages derived from HL-60 cells, previously shown to mimic the interaction of L. pneumophila with human mononuclear phagocytes, were used as host cells for L. pneumophila as previously described (14) .
Plaque assays were performed as described (15) . Dye [3-(4,5- dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, MTT] reduction assays to quantitate cytotoxicity of bacteria were performed as described (14) . It is important to note that antibiotics were not used in any of the assays. The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. were then tested for plaque formation. DNA restriction and Southern hybridization analyses were performed as described (16) .
Aerosol Challenge of Guinea Pigs. Male Hartley strain guinea pigs were cared for as previously described (17) . The animals were challenged by exposure to aerosols containing various doses of bacteria in the same Lucite aerosol chamber described in detail in a previous study (17) . In some cases, bacteria were harvested from guinea pig lung tissue 72 hr after challenge as previously described (18) .
Quantitation of Phagosome-Lysosome Fusion. Monocytederived macrophages (MDM) were isolated as previously described (19) . Lysosomes of MDM were labeled with the electron-opaque marker thorium dioxide as described, washed, and infected with bacteria at a concentration of 1011 per ml for 0.5 hr. MDM were washed to remove nonadherent bacteria, incubated for 1, 5, or 24 hr, and processed for electron microscopy as previously described (1) . Phagosomes containing bacteria were examined for the presence or absence of thorium dioxide and for the presence of smooth vesicles, mitochondria, and ribosomes closely apposed to the external phagosomal membrane.
RESULTS
Establishment of a Plaque Assay to Isolate an Icm+ Derivative of 25D. When we infected monolayers of differentiated HL-60 cells with different numbers of L. pneumophila strain Philadelphia-1, we observed diffuse, irregularly shaped plaques that were clearly visible against the darker background ofliving cells that stained with the neutral red dye (not shown). We determined that the plaquing efficiency of wildtype bacteria was 43% by counting the number ofplaques that different numbers of colony-forming units (cfu) produced on HL-60 macrophage monolayers.
To establish if plaque formation depends on the capacity of the bacteria to multiply intracellularly, we examined two types of mutants unable to grow intracellularly: a thymidine auxotroph, CS140 (20) , and an avirulent strain, 25D (7). Neither strain formed plaques even when >105 cfu were added to the monolayers. The thymidine-requiring strain did form plaques in the presence of thymidine at 100 ,ug/ml (not shown).
To search for genomic fragments of wild-type L. pneumophila DNA that could restore an Icm+ phenotype to the 25D strain we first isolated a streptomycin-resistant, restriction-deficient derivative of 25D to facilitate genetic manipulations (21). When we introduced a library of Philadelphia-i DNA generated in plasmid pAM2 into AM240 by conjugation, we obtained a large number of Gmr bacteria. On HL-60 monolayers, these bacteria produced 21 plaques. In a parallel experiment, an equal number of Gmr AM240 containing the pAM2 vector did not produce any plaques, consistent with our observation that 25D does not revert to an Icm+ phenotype. Bacteria obtained from the plaques were pooled and cultured in HL-60 macrophages to maintain selection for bacteria capable of intracellular growth. Plasmid DNA from these bacteria was prepared and used to transform AM240. All Gmr transformants obtained from pool 2F formed plaques on HL-60 monolayers.
To verify that the Icm+ phenotype is linked to the cosmid, we cured the pAM2-2F plasmid by mating incompatible plasmid pRK24::Tn9 into one of the complemented strains. We selected transconjugants on ABCYE plates containing chloramphenicol and streptomycin and screened them for loss of the pAM2-2F cosmid marker, Gmr. None of 24 chloramphenicol-resistant, gentamicin-sensitive colonies were able to form plaques on HL-60 monolayers (data not shown). These results indicate that the Icm+ phenotype is linked to the cosmid and that the icm mutation in strain 25D is recessive.
Because of the strong selection used to isolate the Icm+ pAM2-2F clone, it was important to confirm that the cloned 2F DNA was indeed wild type and not mutated in such a way as to bypass the Icm defect. We subcloned a 4.5-kb EcoRI fragment from the pAM2-2F clone in pBluescnipt (Stratagene) and used it to probe a second genomic library in another cosmid vector, pMMB33. One clone (19b) that reacted strongly with the probe complemented the Icm-phenotype of AM240. The properties of AM240 carrying plasmids pAM2-2F and pMMB33(19b) are described in the following sections.
Growth and Killing of Differentiated HL-60 CelLs. To determine the capacity of the complemented strains to multiply intracellularly, we infected HL-60 cells with these strains (Fig. 1) antibiotic. The growth data in Fig. 1 represent the number of cfu determined without antibiotics. We quantitated the abilities of the complemented strains to kill differentiated HL-60 cells by using the modified dye (MTT) reduction assay (14) , the results of which are shown in Fig. 2 Column 2 indicates the concentration, in cfu/ml, of bacteria in the suspension from which the aerosol was generated. Column 3 indicates the number of guinea pigs surviving per number challenged, and column 4 indicates the percent survival. *, P = 0.0002 vs. wild type: t, P = 0.001 vs. 25D; *, P = 1.0 vs. wild type.
Physical Characterization of the iwm Locus. Fig. 3 shows a restriction map of the insert DNA in pMMB33(19b) as well as subclones derived from pMMB33(19b) constructed in pMMB207. One subclone was constructed by cloning a 12-kb EcoRI fragment in plasmid pMMB207; this clone is pAM10 in Fig. 3 . When pAM10 was electroporated into AM240, the resulting transformants formed plaques. Deletions of DNA fragments in the pAM10 insert led to loss of the ability to produce plaques. The only exception is plasmid pAM15; this is a pMMB207 derivative containing the 4-kb BamHI fragment from pAM10. The insert in pAM15 is cloned in the opposite orientation from the others with respect to the Ptac promoter present in pMMB207. It is not known whether plaque formation is the result of low-level transcription from Ptac; one hypothesis is that the natural promoter has been deleted in this subclone and has been replaced by Ptac.
To determine whether the genomes of other L. pneumophila strains have regions homologous to the Philadelphia-1 DNA cloned in pMMB33(19b), we used this plasmid to probe a Southern blot of L. pneumophila strains representing 5 of the 14 known serogroups. The probe hybridized to all of the L. pneumophila strains examined, indicating that they have regions homologous to the cloned DNA. No hybridization was observed to E. coli DNA (data not shown). pMMB33(19b), we challenged guinea pigs with aerosols containing various doses of the bacteria ( Table 2) . As in previous studies, wild-type L. pneumophila was highly virulent, whereas the 25D mutant was unable to kill any guinea pigs, even at the highest dose tested (22) . In contrast, 25D containing the 19b plasmid killed all animals challenged with an aerosol generated from a suspension containing 5 x 109 cfu/ml. This difference in survival was highly significant (P = 0.001, Fisher's exact test). Although the complemented strain was able to kill guinea pigs, the LD100 (100% lethal dose) for this strain appeared to be at least 2-fold higher than for wild-type bacteria. (E) . In contrast to phagosomes containing the complemented strain, phagosomes containing wild-type L. pneumophila were typically surrounded by ribosomes (E, small arrows) at 5 hr and later after infection. (A, x20,500; B, x31,000; C-E, x22,000.)
..' .. elles, including smooth vesicles, mitochondria, and ribosomes, but does not fuse with lysosomes (1, 4) . This suggests the possibility that the capacity ofL. pneumophila to multiply intracellularly is correlated with these phagosomal features. To determine if the complemented strain regains a capacity to interfere with phagosome-lysosome fusion, we infected MDM with the complemented strain or 25D and assayed for phagosome-lysosome fusion at various times after infection by electron microscopy. As shown in Table 3 , in MDM infected with wild-type bacteria, 6-11% of the phagosomes fused with lysosomes at 1, 5, and 24 hr, whereas in MDM infected with 25D, 86-95% of the phagosomes fused at 1-5 hr after infection. The complemented strain exhibited a capacity to interfere with fusion midway between that of 25D and wild-type bacteria: 62-68% of the phagosomes fused at 1, 5, and 24 hr after infection; the difference from wild type may reflect a mixture of bacteria in the complemented strain inoculum that had either retained or lost the 19b plasmid. In the same experiments we assessed the interaction of the phagosomes with host cell organelles ( Table 3 ). Many of the phagosomes containing wild-type bacteria interacted with smooth vesicles, mitochondria, and ribosomes, whereas phagosomes containing the 25D mutant rarely interacted with these organelles. Phagosomes containing the complemented strain closely resembled those containing wild-type bacteria, in terms of association with smooth vesicles and mitochondria (Fig. 4) . However, phagosomes containing the complemented strain interacted infrequently with ribosomes and only at 24 hr after infection. This difference from the wild type might also be attributed to loss of the plasmid from a portion of the population. The observation of phagosomes containing the complemented strain, having a "mixed" phenotype-in which both fusion and organelle recruitment occur-has also been observed when wild-type L. pneumophila grows inside activated monocytes (23) .
DISCUSSION
The intracellular conditions which permit pathogens to survive and multiply are poorly understood. L. pneumophila has rather complex nutritional requirements which are met within specialized vacuoles of human macrophages and unicellular protozooans. Mutant 25D was obtained by a combination of multiple batch and single-colony passages on enriched Muller-Hinton agar, which has been shown to select for avirulent mutants (24) . Therefore the 25D mutant may contain more than a single mutation that decreases its ability to grow intracellularly and cause lethal pneumonia. The fact that the cosmids described in this report restore the ability to grow intracellularly as well as the ability to cause disease argues that if there are multiple defects in the 25D mutant, they are closely linked. The icm locus partially or completely restores the functions lost by the 25D mutant, including the capacity to (i) form a specialized phagosome, (ii) inhibit phagosome-lysosome fusion, (iii) multiply intracellularly, and (iv) cause illness and death from pneumonia in guinea pigs. The icm locus must supply gene products which are important in determining the intracellular fate of L. pneumophila. At the present time we do not know if these gene products are highly specific for the intracellular pathogenesis of legionnaires' disease and are required to somehow modify the endosomal pathway to meet the particular metabolic needs of this organism. Alternatively, they may represent functions common to other intracellular pathogens which are required to take full advantage of the phagosomal milieu. Further characterization of this locus, including the phenotypes of defined mutations in the chromosomal locus, will clarify how Legionella and other intracellular pathogens have adapted to the intraphagosomal environment.
